GLOBE NEWSWIRE
Dublin, June 20, 2025 – The neurophotonics market is expected to grow by USD 1.72 billion from 2024 to 2029, exhibiting a CAGR of 12.6 % over the forecast period. This comprehensive report provides market sizing and trends, identifies growth drivers and challenges, and features a vendor analysis of around 25 industry players.
The report examines the current market landscape and highlights key trends and growth drivers, such as the increasing prevalence of neurological disorders, rising cases of brain tumors, and growing investments in neuroscience research.
It outlines opportunities for future market expansion, including initiatives from governments and healthcare organizations, and increased demand for precise neurological diagnostics.
The report utilizes both primary and secondary data, along with insights from industry participants, to present detailed market sizing, regional segmentation, and vendor landscapes. It also includes historical data and forward-looking projections for a comprehensive view.
Market segmentation includes:
- By Application: Research; Therapeutics
- By Type: Microscopy; Spectroscopy; Multimodal
- By End-User: Academic and research institutes; Hospitals and clinics; Pharmaceutical & biotechnology; Neurotechnology startups
- By Region: North America; Europe; Asia; Rest of the World
Vendor analysis covers leading companies such as Carl Zeiss AG, Femtonics Ltd., Hitachi Ltd., Thermo Fisher Scientific Inc., Leica Microsystems, Artinis Medical Systems, and others.
You can read the original release HERE.
